Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8895723 Methods of preparing substituted nucleotide analogs

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88957230

Patent Inventor Names

Cavan McKeon Bligh0

Jyanwei Liu0

Leonid Beigelman0

Luigi Anzalone0

Peter Jamison Rose0

Shereen Ibrahim0

Vladimir Serebryany0

Young Chun Jung0

Date of Patent

November 25, 2014

Patent Application Number

138454150

Date Filed

March 18, 2013

Patent Citations Received

‌

US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

‌

US Patent 11690860 Treatment of HCV infected patients with cirrhosis

‌

US Patent 11707480 Highly active compounds against COVID-19

‌

US Patent 11975016 2′-substituted-N

‌

US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

Patent Primary Examiner

‌

Patrick Lewis

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8895723 Methods of preparing substituted nucleotide analogs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API